Skip to main content

US ClosedU.S. Closed

FDMT: 4D Molecular Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology.

52W Range

79thpctl

Volume

1.25×avg

Market Cap

766.89MUSD

P/E Ratio

-5.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

4D Molecular Therapeutics, Inc.

FDMTNASDAQ Global Select·USD·Closed

4D Molecular Therapeutics, Inc.

FDMTNASDAQ·USD·Closed

$14.67

−1.61%

$14.67

−$0.24 (1.61%)

52W Range

79thpctl

Volume

1.25×avg

Mkt Cap

766.89MUSD

P/E

-5.4TTM

Div Yield

–ann